Targeting the Nuclear Transport Machinery by Rational Drug Design

E-ISSN： 1873-4286|19|12|2318-2325

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.12, 2013-04, pp. : 2318-2325

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A perspective on rational drug design with cyclopentenone: targeting the proteome with the cyclopentenone chemical moiety

By Conti Matteo

Expert Opinion on Drug Discovery, Vol. 2, Iss. 9, 2007-09 ,pp. : 1153-1159

Informa Healthcare

Access to resources Recommend Favorite

Targeting thrombin - rational drug design from natural mechanisms

By Huntington J.A. Baglin T.P.

Trends in Pharmacological Sciences, Vol. 24, Iss. 11, 2003-11 ,pp. : 589-595

Elsevier

Access to resources Recommend Favorite

Targeting Cysteine Proteases from Plasmodium falciparum: A General Overview, Rational Drug Design and Computational Approaches for Drug Discovery

Current Drug Targets, Vol. 19, Iss. 5, 2018-03 ,pp. : 501-526

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies in the Rational Drug Design

Current Medicinal Chemistry, Vol. 18, Iss. 17, 2011-06 ,pp. : 2517-2530

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Catechol-O-Methyl Transferase (COMT) Inhibitors for Schizophrenia:An Approach to Target Validation and Rational Drug Design

Letters in Drug Design & Discovery, Vol. 8, Iss. 3, 2011-03 ,pp. : 246-252

Bentham Science Publishers

Access to resources Recommend Favorite